William L. Heyward
Keine laufenden Positionen mehr
Profil
William L.
Heyward worked as a Vice President at VaxGen, Inc. from 2000 to 2004.
He also worked as a Vice President-Clinical Research at Dynavax Technologies Corp.
in 2010-2011 and as a Vice President-Clinical Development at Osel, Inc. Dr. Heyward received his undergraduate degree from Emory University, his graduate degree from The Johns Hopkins University, and his doctorate from Georgia Health Sciences University.
Ehemalige bekannte Positionen von William L. Heyward
| Unternehmen | Position | Ende |
|---|---|---|
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Osel, Inc.
 Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
| DYNAVAX TECHNOLOGIES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von William L. Heyward
| Emory University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Georgia Health Sciences University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | Health Technology |
